市場調査レポート

SLITタブレット、自己投与およびアレルギー免疫療法:製品・企業・市場・予測

SLIT Tablets, Self-Administration, and Allergy Immunotherapy to 2022 - Products, Players, Markets, and Forecasts

発行 Greystone Research Associates 商品コード 324586
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
SLITタブレット、自己投与およびアレルギー免疫療法:製品・企業・市場・予測 SLIT Tablets, Self-Administration, and Allergy Immunotherapy to 2022 - Products, Players, Markets, and Forecasts
出版日: 2015年02月17日 ページ情報: 英文
概要

当レポートでは、世界のアレルギー免疫療法市場について調査し、アレルギーのタイプおよび治療法別の市場分析を提供しており、主要国・地域の規制動向、主要企業のプロファイルなどをまとめ、お届けいたします。

エグゼクティブサマリー

アレルギー免疫療法市場のダイナミクス

  • 競合情勢
  • アレルギー免疫療法市場
  • アレルギー市場の区分
  • 花粉型アレルギー
  • アレルギー疾患における大気汚染の影響の可能性
  • イエダニ
  • ペットアレルギー
  • 食品アレルギー
  • 治療市場の区分
  • 登録患者向け医薬品
  • 処方薬
  • 新しい治療区分
  • 合成ペプチドエピトープ
  • リンパ管内投与 (ILIT投与)
  • 経皮投与
  • 次世代AIT
  • 組み換えアレルゲン
  • アレルギー治療技術のプラットフォーム
  • 連続重複合成ペプチド (COP)
  • 舌下錠免疫療法
  • SLITタブレット製剤 (舌下免疫療法タブレット製剤)
  • アジュバントの潜在的役割
  • 認可済みSLITタブレット製品
  • 米国
  • 欧州
  • 開発段階にある舌下アレルギータブレット
  • Birch
  • Dust Mite
  • Grass
  • Ragweed
  • 市場データ・予測
  • 市場要因
  • 規制要因・課題
  • 米国
  • 欧州
  • 日本
  • 登録患者向けから処方型マーケティングへの移行
  • OTC鼻炎治療製品に対する市場インパクト
  • 治験および創薬
  • マネージドケア・医療経済
  • 企業プロファイル
目次
Product Code: SLT397K

Immunotherapy involves the administration of gradually increasing doses of the allergen over a period of time to desensitize the patient. It is the only known treatment that modifies the immune response and treats the cause rather than the symptoms. In the United States, the only licensed route of administration is subcutaneous injection (SCIT). An alternative to SCIT is sublingual immunotherapy (SLIT). The medication is kept beneath the tongue where it is absorbed into the mucosa. Though complex and not fully characterized mechanisms, administration of allergens through the oral, gingival, or sublingual mucosa can decrease the allergic response thus desensitizing the patient by modifying disease at least temporarily if not permanently (i.e. inducing tolerance). The incidence of severe or serious AE associated with SLIT is significantly lower than with SCIT such that SLIT which may be self-administered at home, while safe use of SCIT requires administration in a clinic that is capable of responding to systemic allergic reactions.

What You Will Learn

  • What approved allergy immunotherapeutics (AIT) are currently marketed, how are they administered, what are the device specifics, and who markets them?
  • Who are the important AIT suppliers, their manufacturing infrastructure and locations, their capabilities?
  • What are the major factors driving demand for self-administered AIT products including SLIT tablets?
  • How important are manufacturer relationships and what are the key alliances in the industry?
  • What are the essential factors, issues, technologies and market development issues for self-administered AIT products?
  • What are the significant economic, technology, and regulatory factors affecting AIT products?

Table of Contents

  • Executive Summary
  • Allergy Immunotherapy Market Dynamics
  • Competitive Landscape
  • The Market for Allergy Immunotherapy
  • Allergen Market Segments
  • Pollen-based Allergies
  • Possible Effects of Air Pollution in Allergic Diseases
  • Dust Mites
  • Pet Allergies
  • Food Allergies
  • Therapeutic Market Segments
  • Named Patient Products
  • Prescription Products
  • Emerging Therapeutic Segments
  • Synthetic Peptide Epitopes
  • Intralymphatic (ILIT) Administration
  • Epicutaneous Administration
  • Next Generation AIT
  • Recombinant Allergens
  • Allergy Therapeutics Technology Platforms
  • Contiguous Overlapping Peptides (Anergis)
  • Sublingual Tablet Immunotherapy
  • SLIT Tablet Formulations
  • The Potential Role of Adjuvants
  • Approved SLIT Tablet Products
  • U.S.
  • Europe
  • Development-stage Sublingual Allergen Tablets
  • Birch
  • Dust Mite
  • Grass
  • Ragweed
  • Market Data and Forecasts
  • Market Factors
  • Regulatory Factors and Issues
  • United States
  • Europe
  • Japan
  • The Shift from Named Patient to Prescription-based Marketing
  • The Market Impact on OTC Rhinitis Treatment Products
  • Clinical Trials and Product Development
  • Managed Care & Healthcare Economics
  • Company Profiles
Back to Top